Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Reinhard Dummer(University of Zurich), Ulrich Keilholz(Berliner Hochschule für Technik), Nicole Lindenblatt(University Hospital of Zurich), George Pentheroudakis(University of Ioannina), Axel Hauschild(Kiel University)

Annals of Oncology

August 27, 2015

10.1093/annonc/mdv297

Cited by 393

Related Papers

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

|New England Journal of Medicine|2011|7.7k

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

|The Lancet|2012|3k

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

|Nature|2010|1.4k

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

|Blood|2007|1.4k

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

|New England Journal of Medicine|2017|1.4k